Regentis Biomaterials Ltd. (RGNT) — Cash Flow Quality Index

Latest as of December 2024: -0.13x

Regentis Biomaterials Ltd. (RGNT) has a Cash Flow Quality Index of -0.13x as of December 2024. Operating cash flow of $-641.00K is below net income of $4.80 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RGNT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.13x
Operating CF / Net Income

Operating Cash Flow

$-641.00K
USD

Net Income

$4.80 Million
USD

Data as of

Dec 2024
Most recent filing

Regentis Biomaterials Ltd. Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Regentis Biomaterials Ltd. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See RGNT net asset quality index to measure how much of total assets are equity-financed.

Annual Cash Flow Quality Index for Regentis Biomaterials Ltd. (2024–2024)

Year-by-year earnings quality comparison for Regentis Biomaterials Ltd.. For the full cash flow conversion analysis, see cash efficiency ratio of Regentis Biomaterials Ltd..

Year Quality Index Operating CF (USD) Net Income YoY Change
2024 -0.13x $-641.00K $4.80 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.